

Wall Street analysts initiate coverage on Lumexa Imaging, citing advanced imaging growth, expanding centers, and a resilient sales model.
You can purchase shares of Lumexa Imaging Hldgs (NASDAQ:LMRI) through any online brokerage.
Other companies in Lumexa Imaging Hldgs’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
Lumexa Imaging Hldgs has a consensus price target of $20.56.
The stock price for Lumexa Imaging Hldgs (NASDAQ: LMRI) is $15.88 last updated November 11, 2026 at 11:47 AM EST.
There are no upcoming dividends for Lumexa Imaging Hldgs.
Lumexa Imaging Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Lumexa Imaging Hldgs.
Lumexa Imaging Hldgs is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two...